Docetaxel (Northstar RxLLC)
Welcome to the PulseAid listing for the Docetaxel drug offered from Northstar RxLLC. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Northstar RxLLC |
NON-PROPRIETARY NAME: | Docetaxel |
SUBSTANCE NAME: | DOCETAXEL ANHYDROUS |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-01-01 |
END MARKETING DATE: | 0000-00-00 |
Docetaxel HUMAN PRESCRIPTION DRUG Details:
Item Description | Docetaxel from Northstar RxLLC |
LABELER NAME: | Northstar RxLLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2016-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 16714-465_413f5320-514e-6fbd-e054-00144ff8d46c |
PRODUCT NDC: | 16714-465 |
APPLICATION NUMBER: | NDA201195 |
Other DOCETAXEL ANHYDROUS Pharmaceutical Manufacturers / Labelers: